Show simple item record

dc.contributor.authorDitto, Jessica
dc.contributor.authorBundy, Elaine Y.
dc.date.accessioned2022-03-10T16:42:43Z
dc.date.available2022-03-10T16:42:43Z
dc.date.issued2022-03-23
dc.identifier.urihttp://hdl.handle.net/10713/18192
dc.descriptionPoster presented at the National Association of Pediatric Nurse Practitioners, National Conference, March 23, 2022.en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAntipsychotic Agentsen_US
dc.subject.meshMetabolic Syndromeen_US
dc.subject.meshMonitoring, Physiologicen_US
dc.titleImproving Laboratory Monitoring of Metabolic Parameters in Patients Taking Antipsychotic Medicationsen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-03-10T16:42:44Z


Files in this item

Thumbnail
Name:
SON_Ditto_2022.pdf
Size:
440.6Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International